11/16/2026 | Press release | Distributed by Public on 11/16/2026 13:22
Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of our financial condition and results of operations should be read in conjunction with the audited and unaudited consolidated financial statements and the notes to those statements included elsewhere in this Report. This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in this Report that could cause actual results to differ materially from those anticipated in these forward-looking statements.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements, including, without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources. Investors are cautioned that such forward-looking statements involve risks and uncertainties including without limitation the following: (i) our plans, strategies, objectives, expectations and intentions are subject to change at any time at our discretion; (ii) our plans and results of operations will be affected by our ability to manage growth; and (iii) other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.
In some cases, you can identify forward-looking statements by terminology such as ''may,'' ''will,'' ''should,'' ''could,'' ''expects,'' ''plans,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We are under no duty to update any of the forward-looking statements after the date of this Report.
This section of the report should be read together with Footnotes of the Company's audited consolidated financials for the year ended June 30, 2026. The unaudited condensed consolidated statements of operations for the three months ended September 30, 2026 and 2025 are compared in the sections below.
Executive Summary
Xeriant is dedicated to the discovery, development, and commercialization of transformative technologies, with a focus on advanced materials that can be successfully integrated and deployed across multiple industrial sectors. Xeriant's advanced materials line is marketed under the DUREVER™ brand and includes NexBoard™, a high-performance eco-friendly composite construction panel made from recycled plastic and fiber waste, and NexPatch™, its companion fire-resistant joint compound. Both products use the Company's proprietary fire-retardant technology, called Durazite™. NexBoard™ has shown exceptional resistance to fire, water, mold, insects, cracking, abrasion, compression and puncture, and was designed to become a universal panel to replace products such as drywall, plywood, OSB, MDF, MgO board, cement board and other materials used in construction. Durazite also has potential uses in many industries looking to improve the performance of their products. The Company seeks strategic partners in the building materials industry and other industries for immediate access to their distribution networks and markets.
| 4 |
Joint Venture with XTI Aircraft
Effective May 31, 2021, Xeriant entered into a Joint Venture with XTI Aircraft Company ("XTI"), named Eco-Aero, LLC, with the purpose of completing the preliminary design review ("PDR") of XTI's eVTOL fixed wing aircraft. XTI and the Company each own 50 percent of the XTI JV, and it is managed by a management committee consisting of five members, three appointed by Xeriant and two by XTI. The Company invested approximately $5.5 million into the joint venture after borrowing the funds from Auctus Fund LLC ("Auctus") through a Senior Secured Promissory Note, through an introduction from Maxim Group, LLC, the Company's investment banker at the time. The borrowed funds from Auctus were intended to be a bridge loan that would be resolved through an IPO (Initial Public Offering) and uplist to Nasdaq in a merger with XTI, which did not occur because XTI refused to move forward with the merger. The PDR was completed during the first quarter of 2022 according to XTI, which was the purpose of the joint venture.
On May 17, 2022, Xeriant signed a Letter Agreement with XTI related to the introduction of XTI to Inpixon, a Nasdaq-listed company. Under this Letter Agreement, if there was a combination or other transaction between XTI and Inpixon, Xeriant would receive compensation of 6 percent of XTI fully diluted pre-merger shares, and XTI would assume the obligations of Xeriant's Senior Secured Note with Auctus Fund, LLC. On May 31, 2023, the joint venture was terminated according to an Acceleration Event, which was 24 months from the start of the joint venture. On June 5, 2023, after suspecting that the obligations under the Letter Agreement were possibly being evaded, the Company transmitted a formal demand letter to XTI requesting compliance with the provisions outlined in the Letter Agreement, and in accordance with section 8 of the JV Agreement with XTI. On July 25, 2023, Inpixon filed an 8-K, announcing their intention to merge with XTI having executed an Agreement of Plan and Merger with XTI. The filing also showed that XTI had engaged in a transaction with Inpixon on March 10, 2023, receiving $300,000 in funding, which was a compensation triggering event. Inpixon subsequently filed an S-4/A registration statement on October 6, 2023. On December 6, 2023, the Company initiated legal proceedings against XTI. See Litigation section at Note 9 below for a summary of the related legal proceedings.
Stock Sales
None.
Convertible Notes Issued
During the three months ended September 30, 2026, the Company received $195,000 from issuance of convertible debt. The convertible notes issued during the three months ended September 30, 2026, contain a provision that prevents the Company from prepaying any principal or interest on the notes.
Litigation
Effective October 29, 2025, Xeriant terminated its previously disclosed litigation proceedings with Auctus Fund, LLC, and entered into a Settlement Agreement with Auctus to restructure the Auctus Note and related obligations. Xeriant is currently working on securing funding to fulfill its obligations under the Settlement Agreement and has ongoing discussions with Auctus regarding extending the cash payments based on the Company's timelines in executing its business plan, particularly certification testing of NEXBOARD. The Company's ongoing lawsuit against XTI Aircraft Company has a connection to the Auctus matter in that the Company's obligations to Auctus were, according to Xeriant's complaint, to be assumed by XTI as provided in a Letter Agreement. Separately, Auctus Fund, LLC, sued XTI related to the Letter Agreement.
On December 6, 2023, the Company initiated legal proceedings against XTI Aircraft Company in the Federal District Court for the Southern District of New York (Case no. 1:23-cv-10656-JPO), along with other unnamed defendants, seeking to enforce the terms of the Letter Agreement, alleging fraudulent acts, deceptive maneuvers and intentional breaches, and seeking a range of remedies. These include the recovery of losses, expenses, attorneys' fees, punitive damages and a compensatory damage award exceeding $500 million. The legal action aims to address the alleged misconduct comprehensively and to protect the Company's interests in the face of XTI's actions. The foregoing description of the legal action does not purport to be complete and is subject in its entirety by the full text of the complaint, a copy of which was filed in an 8-K on December 12, 2023, Exhibit 99.1. On February 29, 2025, the Company filed a Second Amended Complaint alleging seven counts including intentional fraud, fraudulent concealment, breach of contract, unjust enrichment, unfair competition, quantum meruit, and misappropriation of confidential information. XTI filed a Motion to Dismiss on March 13, 2025, seeking to dismiss all the Company's claims except for breach of contract. The Company filed a Memorandum of Law in Opposition to XTI's Motion to Dismiss on April 10, 2025, and on January 14, 2025, the Court agreed with the Company's position that its claims were validly alleged and denied all of XTI's arguments in their entirety. On February 18, 2025, XTI filed its answer to the Company's Second Amended Complaint adding two counter claims, including breach of fiduciary duty and breach of contract. The Company responded on March 18, 2025, moving to dismiss both counterclaims and on April 1, 2025, XTI filed a Second Amended Answer and Counterclaims to the Second Amended Complaint. On April 28, 2025, the Company filed a Motion to Dismiss XTI's Second Amended Answer and Counterclaims. On May 12, 2025, XTI filed a Memorandum of Law in Opposition to Xeriant's Motion to Dismiss XTI's Second Amended Counterclaim. On May 20, 2025, Xeriant filed a Memorandum of Law in Support of its Motion to Dismiss XTI's Second Amended Answer with Counterclaims. On September 23, 2025, Xeriant's Motion to dismiss XTI's Second Amended Answer with Counterclaim was denied by the Court. The parties are presently involved in the discovery process. The foregoing descriptions of the legal actions do not purport to be complete and are subject in their entirety by the full text of the court filings.
| 5 |
On July 2, 2025, the Company was served with a complaint from Midland Compounding for breach of contract in the payment of an invoice in the amount of $57,600 related to a purchase order for consulting services related to improving the Company's intumescent fire-retardant layer for NEXBOARD. On August 20, 2025, the Company filed an Answer and Affirmative Defenses, essentially stating that Midland Compounding had not performed the services it was contracted to provide. On August 6, 2026, the Company settled the lawsuit with Midland Compounding by agreeing to make three $10,000 payments by September 30, 2026, and in return getting back equipment and chemicals previously provided by Xeriant. The payments were made and Xeriant is in the process of getting back the equipment and chemicals.
Except as set forth above, there is no pending litigation against the Company and to our knowledge no litigation is contemplated or threatened. To our knowledge, none of our directors, officers, 5% shareholders or affiliates are party to any legal proceedings that would have a material adverse effect on our business, financial condition, or operating results.
Three months Ended September 30, 2026, Results of Operations Compared with Three months Ended September 30, 2025
|
For the three months ended |
||||||||||||
|
September 30, |
||||||||||||
|
2026 |
2025 |
$ |
||||||||||
|
Operating expenses: |
||||||||||||
|
Consulting and advisory fees |
$ | 52,600 | $ | 67,200 | $ | (14,600 | ) | |||||
|
Related party consulting fees |
124,000 | 74,000 | 50,000 | |||||||||
|
General and administrative expenses |
53,902 | 24,912 | 28,990 | |||||||||
|
Professional fees |
98,669 | 83,997 | 14,672 | |||||||||
|
Research and development expense |
48,002 | 53,966 | (5,964 | ) | ||||||||
|
Total operating expenses |
377,173 | 304,075 | 73,098 | |||||||||
|
Operating loss |
(377,173 | ) | (304,075 | ) | (73,098 | ) | ||||||
|
Other expenses: |
||||||||||||
|
Amortization of debt discount |
(99,284 | ) | (44,031 | ) | (55,253 | ) | ||||||
|
Interest expense |
(23,85 | ) | (44,783 | ) | 21,698 | |||||||
|
Gain on extinguishment of debt |
- | 2,743,546 | (2,743,546 | ) | ||||||||
|
Total other (expense) |
(122,369 | ) | 2,654,732 | (2,777,101 | ) | |||||||
|
Income tax expense |
- | (124,585 | ) | (124,585 | ) | |||||||
|
Net (loss) income |
$ | (499,542 | ) | $ | 2,226,072 | $ | (2,725,614 | ) | ||||
Consulting and advisory fees
Total consulting and advisory expenses were $52,600 and $67,200 for the three months ended September 30, 2026 and 2025, respectively, a decrease of $14,600. The decrease was primarily related to a decrease in advisory board fees in the amount of $22,000 relating to timing of board member anniversary dates and slightly offset by an increase in consulting fees in amount of $6,400 due to non-recurring consulting fees.
| 6 |
Related Party Consulting Fees
Total related party consulting fees were $124,000 and $74,000 for the three months ended September 30, 2026 and 2025, respectively, an increase of $50,000. In the current period, the Company had more funds to pay consulting fees whereas in the prior period the Company had less funds to pay consulting fees and the related parties agreed to accept reduced amounts of compensation for the same amount of services rendered.
General and administrative expenses
Total general and administrative expenses were $53,902 and $24,912 for the three months ended September 30, 2026 and 2025, respectively, an increase of $28,990. The primary reasons for the increase were (i) an increase in public relation expense of $9,250 and (ii) $15,554 increase in travel expenses in the current period.
Professional Fees
Total professional fees were $98,669 and $83,997 for the three months ended September 30, 2026 and 2025, respectively, an increase of $14,672. The primary reason for the increase was higher legal fees in the amount of $11,900 in the current period.
Research and Development Expenses
Total research and development expenses were $48,002 and $53,966 for the three months ended September 30, 2026, and 2025, respectively, a decrease of $5,964. The primary reason for the decrease was increased research and development expenses related to testing and initial product development schedule in the prior period.
Other (Expenses)
Total other expenses consist of amortization of debt discount related to convertible notes, interest expense related to convertible notes and gain on extinguishment of debt. Total other expense was $122,369 for the three months ended September 30, 2026, compared to $2,654,732 in other income for the three months ended September 30, 2025, a decrease of $2,777,101. The reason for the income in the current period was the Company recorded a gain on extinguishment of debt in the amount of $2,743,546 related to the settlement with Auctus.
Net income (loss)
Total net loss was $499,542 for the three months ended September 30, 2026, compared to net income of $2,226,072 for the three months ended September 30, 2025, an increase of $2,725,614. The reason for the net income in the prior period was the Company recorded a gain on extinguishment of debt in the amount of $2,743,546 related to the settlement with Auctus.
| 7 |
Liquidity and Capital Resources
The Company's unaudited condensed consolidated financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. On September 30, 2026, and June 30, 2026, the Company had $39,255 and $87,594 in cash, respectively, and $5,038,605 and $4,897,313 in negative working capital, respectively. For the three months ended September 30, 2026, the Company had a net loss of $499,542 and for the three months ended September 30, 2025, the Company had net income of $2,226,072. Continued losses may adversely affect the liquidity of the Company in the future. Therefore, the factors noted above raise substantial doubt about our ability to continue as a going concern. The recoverability of a major portion of the recorded asset amounts shown in the accompanying unaudited condensed consolidated balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to raise additional capital, obtain financing and to succeed in its future operations. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. To implement its business plan, the Company must raise sufficient funds in the form of equity, debt, or a combination thereof. Until the Company develops profitable operations, it is dependent upon management continually raising funds.
During the three months ended September 30, 2026, the Company's operating activities used $243,339 of cash compared to $177,714 of net cash used in operating activities during the three months ended September 30, 2025. This difference related to the change in net income (loss) in the amount of $2,725,614 along with an aggregate increase of $2,835,399 in depreciation and amortization, amortization of debt discount, gain on extinguishment of debt, amortization of right of use asset, prepaids and deposits, and accrued liability-related party, offset by an aggregate decrease of $175,410 in stock issued for services, accounts payable and accrued liabilities, taxes payable and lease liabilities. During the three months ended September 30, 2026, the Company's financing activities provided cash of $195,000 compared to $185,000 in the prior period. The cash provided by financing activities in both periods was from proceeds from convertible notes payable.
Effective October 29, 2025, Xeriant entered into a Settlement Agreement with Auctus to restructure the Auctus Note and related Xeriant obligations. The Settlement Agreement provides that the Company pay Auctus $3,500,000 as follows: (A) $1,000,000 on or before 75 days from October 29, 2025; (B) $1,000,000 on or before 105 days from October 29, 2025;(C) $1,000,000 on or before 135 days from October 29, 2025; and (D) $500,000 on or before 165 days from October 29, 2025. In addition, within ten (10) business days of receipt by the Company of any money or any other consideration pertaining to the legal action brought by the Company against XTI Aircraft Company, the Company will transfer litigation proceeds to Auctus on a preferred basis and share on a percentage basis thereafter net of legal fees not to exceed $250,000. The Settlement Agreement was subsequently extended through July 31, 2026, and again extended through October 31, 2026. On October 29, 2026, Auctus agreed to extend the terms of the agreement until December 31, 2026. The terms of the agreement are in the process of being finalized. There is no assurance that the Company will raise the funds necessary to meet these obligations of the Settlement Agreement or that there will be proceeds from the litigation against XTI Aircraft. The foregoing terms from the Settlement Agreement relate to liquidity and are only a portion of those found in the Settlement Agreement. This paragraph is qualified in its entirety by the terms and conditions set forth in Form 8-K filed with the SEC on November 12, 2025.
| 8 |
Off Balance Sheet Items
We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as "special purpose entities" (SPEs).
Critical Accounting Policies
Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments which affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities (see Note 2, Summary of Significant Accounting Policies, contained in the notes to the Company's unaudited condensed consolidated financial statements for the three months ended September 30, 2026 and 2025 contained in this filing). On an ongoing basis, we evaluate our estimates. The Company bases our estimates on historical experience and on various other assumptions which we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities which are not readily apparent from other sources. Actual results may differ from these estimates based upon different assumptions or conditions; however, we believe that our estimates are reasonable.
Management is aware that certain changes in accounting estimates employed in generating financial statements can have the effect of making the Company look more or less profitable than it actually is. Management does not believe that the Company has made any such changes in accounting estimates.